cross-posted from: https://lemmit.online/post/3641151

This is an automated archive made by the Lemmit Bot.

The original was posted on /r/cfs by /u/shallah on 2024-08-09 23:12:51+00:00.


The study could also help researchers create diagnostic tools for evaluating which patients have Long COVID induced by autoimmunity so that doctors can identify who is most likely to benefit from treatments such as these.

Iwasaki plans to continue researching why and how autoantibodies might cause Long COVID, as well as conduct randomized clinical trials on promising treatments. She is also conducting similar antibody transfer studies in other post-acute infection syndromes, such as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).